All Articles

Facing a silent crisis in its vast underwater prairies, Indonesia is pioneering a new collaborative framework to unify fragmented data and save its vital seagrass.

ePLDT's new alliance with Vantiq aims to move Philippine AI from theory to real-time action, bolstering digital sovereignty and reshaping the national tech landscape.

Freedom Holding Corp. secured a key S&P upgrade for its subsidiaries, bolstering its aggressive global expansion. But can its risk controls keep pace?

A stunning 12GWh in deals from a single event signals more than a company win; it reveals the new rules of the global energy storage race. Here's why.

NuCube Energy is going public via a $500M SPAC deal to fund its microreactors. Can this high-stakes bet deliver clean power to data centers and industry?

A £1.3M debt dispute escalates as the National Bank of Uzbekistan pursues Solfy CA in English courts, alleging a smear campaign to derail justice.

Summer trip costs are soaring to nearly $10,000, yet travelers are buying less insurance. We uncover the five critical errors that could cost you everything.

Hyundai secures top JD Power rankings by focusing on fundamentals, a stark contrast to an industry where improving quality is undermined by tech frustrations.

Professor Jason Chin’s Heinrich Wieland Prize signals a new era. His work in synthetic biology is enabling Constructive Bio to forge a new class of drugs.

At Intersolar 2026, Astronergy unveiled its ASTRO N7s 3.0. Beyond the efficiency gains, the real story is how it redefines the residential solar market.

Carolyn Starrett's appointment to the NeoGenomics board signals a major push to integrate AI and real-world data into the core of cancer diagnostics.

Mark Cravotta’s jump to Spektrum Labs isn't just a career move. It’s a bet on the shift from cybersecurity to provable resilience as the new benchmark.

A landmark survey reveals a stunning bipartisan mandate on reproductive health, showing a vast majority of Republican voters support protecting access to EC.

Beyond the press release, MegaGen's investment in BIOLASE is a strategic masterclass in post-acquisition revival, aiming to dominate the dental tech market.

Analyst firm QKS Group names Compass Plus a leader, but the real story is how its modern, API-first architecture is rewiring card payments for banks.

The sudden death of veteran counsel E. Forrest Jones Jr. leaves a void at Ramaco Resources, testing its leadership amid a high-stakes pivot to critical minerals.

Aidoc's 'First Read' AI has earned a coveted FDA Breakthrough designation, promising to ease radiologist workload. But can an algorithm be trusted with your health?

With its stock lagging despite strong sales, Insulet brings on a proven value-creator. Can the 'Mazelsky Playbook' accelerate growth and fend off rivals?

UpDoc just secured the first FDA clearance for a patient-facing clinical AI. This isn't just another app; it's a new paradigm for healthcare delivery.